Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Acute Ischaemic Stroke
2023-506178-11-00Phase 3Suspended
- Sponsor
- Karolinska Institutet
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain infarction comparing Imatinib with Placebo (2 arms). Primary endpoint: Shift in modified Rankin Scale at 3 months. Started Nov 2023; status: suspended.
02
Drugs
03
Conditions
brain infarction
Beyond the preview
Go deeper on 2023-506178-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506178-11-00.